Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Equity Ratio (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Equity Ratio for 4 consecutive years, with 0.71 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 55.52% to 0.71 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.71 through Dec 2025, up 55.52% year-over-year, with the annual reading at 0.71 for FY2025, 55.52% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.71 at Century Therapeutics, down from 0.72 in the prior quarter.
  • The five-year high for Equity Ratio was 0.76 in Q1 2025, with the low at 0.46 in Q4 2024.
  • Average Equity Ratio over 4 years is 0.62, with a median of 0.61 recorded in 2022.
  • The sharpest move saw Equity Ratio dropped 17.68% in 2023, then soared 55.52% in 2025.
  • Over 4 years, Equity Ratio stood at 0.62 in 2022, then decreased by 17.68% to 0.51 in 2023, then dropped by 10.81% to 0.46 in 2024, then skyrocketed by 55.52% to 0.71 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.71, 0.72, and 0.74 for Q4 2025, Q3 2025, and Q2 2025 respectively.